SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo Jorg Hendle, Patrick S. Lee, et al. Mol Cancer Ther 2009;8:3181-3190
http://nci.nih.gov/drugdictionary/?CdrID=588972 http://nci.nih.gov/drugdictionary/?CdrID=588972 ;
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.